Hims & Hers bigger-than-expected quarterly loss overshadows revenue forecast raise
NEW YORK, Aug 10 (Reuters) - Hims & Hers Health on Monday posted a bigger-than-expected second-quarter loss as the telehealth company's shift to branded weight-loss drugs drove up costs. Shares of the company were down 5% in after-hours trading, even though Hims raised its annual revenue forecast. 
